Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 23

1.

Acute and late side effects to salivary glands and oral mucosa after head and neck radiotherapy in children and adolescents. Results of the "Registry for the evaluation of side effects after radiotherapy in childhood and adolescence"

Bölling T, Weege J, Eich HT, Timmermann B, Meyer FM, Rübe C, Kortmann RD, Fischedick K, Rödel C, Koch R, Willich N.

Head Neck. 2014 Apr 25. doi: 10.1002/hed.23715. [Epub ahead of print]

PMID:
24764129
[PubMed - as supplied by publisher]
2.

Fat necrosis and parenchymal scarring after breast-conserving surgery and radiotherapy with an intraoperative electron or fractionated, percutaneous boost: a retrospective comparison.

Piroth MD, Fischedick K, Wein B, Heindrichs U, Piroth DM, Holy R, Pinkawa M, Eble MJ.

Breast Cancer. 2014 Jul;21(4):409-14. doi: 10.1007/s12282-012-0418-2. Epub 2012 Oct 17.

PMID:
23073742
[PubMed - in process]
3.

N Latex FLC - new monoclonal high-performance assays for the determination of free light chain kappa and lambda.

te Velthuis H, Knop I, Stam P, van den Broek M, Bos HK, Hol S, Teunissen E, Fischedick KS, Althaus H, Schmidt B, Wagner C, Melsert R.

Clin Chem Lab Med. 2011 Aug;49(8):1323-32. doi: 10.1515/CCLM.2011.624. Epub 2011 Jun 10.

PMID:
21663464
[PubMed - indexed for MEDLINE]
4.

Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the "Registry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence" (RiSK).

Bölling T, Geisenheiser A, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e787-91. doi: 10.1016/j.ijrobp.2010.10.037. Epub 2010 Dec 16.

PMID:
21167655
[PubMed - indexed for MEDLINE]
5.

Quality of life after whole pelvic versus prostate-only external beam radiotherapy for prostate cancer: a matched-pair comparison.

Pinkawa M, Piroth MD, Holy R, Fischedick K, Klotz J, Székely-Orbán D, Eble MJ.

Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):23-8. doi: 10.1016/j.ijrobp.2010.05.054. Epub 2010 Sep 9.

PMID:
20832182
[PubMed - indexed for MEDLINE]
6.

Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium.

Bölling T, Ernst I, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Willich N.

Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):840-4. doi: 10.1016/j.ijrobp.2010.03.021. Epub 2010 Jul 16.

PMID:
20638187
[PubMed - indexed for MEDLINE]
7.

Acute toxicity profile of radiotherapy in 690 children and adolescents: RiSK data.

Selo N, Bölling T, Ernst I, Pape H, Martini C, Rübe C, Timmermann B, Fischedick K, Kortmann RD, Gerss J, Koch R, Willich N.

Radiother Oncol. 2010 Oct;97(1):119-26. doi: 10.1016/j.radonc.2010.04.030. Epub 2010 May 31.

PMID:
20605649
[PubMed - indexed for MEDLINE]
8.

Consequential late effects after radiotherapy for prostate cancer - a prospective longitudinal quality of life study.

Pinkawa M, Holy R, Piroth MD, Fischedick K, Schaar S, Székely-Orbán D, Eble MJ.

Radiat Oncol. 2010 Apr 8;5:27. doi: 10.1186/1748-717X-5-27.

PMID:
20377874
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Prostate-specific antigen kinetics following external-beam radiotherapy and temporary (Ir-192) or permanent (I-125) brachytherapy for prostate cancer.

Pinkawa M, Piroth MD, Holy R, Fischedick K, Schaar S, Borchers H, Heidenreich A, Eble MJ.

Radiother Oncol. 2010 Jul;96(1):25-9. doi: 10.1016/j.radonc.2010.02.010. Epub 2010 Mar 16.

PMID:
20231039
[PubMed - indexed for MEDLINE]
10.

Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.

Pinkawa M, Piroth MD, Fischedick K, Holy R, Klotz J, Nussen S, Krenkel B, Eble MJ.

Strahlenther Onkol. 2009 Nov;185(11):724-30. doi: 10.1007/s00066-009-2008-6. Epub 2009 Nov 10.

PMID:
19899005
[PubMed - indexed for MEDLINE]
11.

Self-assessed bowel toxicity after external beam radiotherapy for prostate cancer--predictive factors on irritative symptoms, incontinence and rectal bleeding.

Pinkawa M, Piroth MD, Fischedick K, Nussen S, Klotz J, Holy R, Eble MJ.

Radiat Oncol. 2009 Sep 21;4:36. doi: 10.1186/1748-717X-4-36.

PMID:
19772568
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Impact of age and comorbidities on health-related quality of life for patients with prostate cancer: evaluation before a curative treatment.

Pinkawa M, Fischedick K, Gagel B, Piroth MD, Asadpour B, Klotz J, Borchers H, Jakse G, Eble MJ.

BMC Cancer. 2009 Aug 24;9:296. doi: 10.1186/1471-2407-9-296.

PMID:
19703300
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Neoadjuvant hormonal therapy and external-beam radiotherapy versus external-beam irradiation alone for prostate cancer. A quality-of-life analysis.

Pinkawa M, Piroth MD, Asadpour B, Gagel B, Fischedick K, Siluschek J, Kehl M, Krenkel B, Eble MJ.

Strahlenther Onkol. 2009 Feb;185(2):101-8. doi: 10.1007/s00066-009-1894-y. Epub 2009 Feb 25.

PMID:
19240996
[PubMed - indexed for MEDLINE]
14.

Rectal dosimetry following prostate brachytherapy with stranded seeds--comparison of transrectal ultrasound intra-operative planning (day 0) and computed tomography-postplanning (day 1 vs. day 30) with special focus on sources placed close to the rectal wall.

Pinkawa M, Asadpour B, Piroth MD, Gagel B, Klotz J, Fischedick K, Borchers H, Jakse G, Eble MJ.

Radiother Oncol. 2009 May;91(2):207-12. doi: 10.1016/j.radonc.2008.11.012. Epub 2008 Dec 25.

PMID:
19100642
[PubMed - indexed for MEDLINE]
15.

Erectile dysfunction after external beam radiotherapy for prostate cancer.

Pinkawa M, Gagel B, Piroth MD, Fischedick K, Asadpour B, Kehl M, Klotz J, Eble MJ.

Eur Urol. 2009 Jan;55(1):227-34. doi: 10.1016/j.eururo.2008.03.026. Epub 2008 Mar 24.

PMID:
18375048
[PubMed - indexed for MEDLINE]
16.

Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.

Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Holy R, Krenkel B, Eble MJ.

Radiother Oncol. 2008 Jul;88(1):135-9. Epub 2007 Nov 19.

PMID:
18022263
[PubMed - indexed for MEDLINE]
17.

Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer.

Pinkawa M, Fischedick K, Asadpour B, Gagel B, Piroth MD, Nussen S, Eble MJ.

Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):83-9. Epub 2007 Sep 12.

PMID:
17855010
[PubMed - indexed for MEDLINE]
18.

Prostate-specific antigen kinetics after brachytherapy or external beam radiotherapy and neoadjuvant hormonal therapy.

Pinkawa M, Fischedick K, Piroth MD, Gagel B, Borchers H, Jakse G, Eble MJ.

Urology. 2007 Jan;69(1):129-33.

PMID:
17270634
[PubMed - indexed for MEDLINE]
19.

Health-related quality of life after permanent interstitial brachytherapy for prostate cancer: correlation with postimplant CT scan parameters.

Pinkawa M, Fischedick K, Piroth MD, Gagel B, Borchers H, Jakse G, Eble MJ.

Strahlenther Onkol. 2006 Nov;182(11):660-5.

PMID:
17072524
[PubMed - indexed for MEDLINE]
20.

Association of neoadjuvant hormonal therapy with adverse health-related quality of life after permanent iodine-125 brachytherapy for localized prostate cancer.

Pinkawa M, Fischedick K, Gagel B, Piroth MD, Borchers H, Jakse G, Eble MJ.

Urology. 2006 Jul;68(1):104-9. Epub 2006 Jun 27.

PMID:
16806434
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk